E
Xtant Medical Holdings, Inc.
XTNT
$0.6019
$0.00871.47%
E
Sell
6/4/2024Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 6/4/2024 due to a decline in the volatility index, valuation index and total return index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 6/4/2024 due to a decline in the volatility index, valuation index and total return index.
D
Sell
4/2/2024Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D from D+ on 4/2/2024 due to a significant decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0205 to -$0.0331, and the quick ratio declined from 1.27 to 1.15.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D from D+ on 4/2/2024 due to a significant decline in the efficiency index, growth index and solvency index. Earnings per share declined from -$0.0205 to -$0.0331, and the quick ratio declined from 1.27 to 1.15.
D
Sell
11/17/2023Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D- on 11/17/2023 due to a significant increase in the efficiency index, total return index and growth index. Net income increased 521.51% from -$2.19M to $9.23M, earnings per share increased from -$0.0201 to $0.07, and total capital increased 42.54% from $54.52M to $77.71M.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D- on 11/17/2023 due to a significant increase in the efficiency index, total return index and growth index. Net income increased 521.51% from -$2.19M to $9.23M, earnings per share increased from -$0.0201 to $0.07, and total capital increased 42.54% from $54.52M to $77.71M.
D
Sell
3/14/2023Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/17/2023Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 2/17/2023 due to an increase in the volatility index and total return index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 2/17/2023 due to an increase in the volatility index and total return index.
D
Sell
11/7/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/7/2022 due to a large decline in the growth index and volatility index. Operating cash flow declined 13,860% from $15 to -$2.06M, earnings per share declined from -$0.02 to -$0.03, and EBIT declined 46.15% from -$1.3M to -$1.9M.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/7/2022 due to a large decline in the growth index and volatility index. Operating cash flow declined 13,860% from $15 to -$2.06M, earnings per share declined from -$0.02 to -$0.03, and EBIT declined 46.15% from -$1.3M to -$1.9M.
D
Sell
5/16/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 05/16/2022.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 5/13/2022 due to a decline in the growth index and total return index. Operating cash flow declined 337.35% from $423 to -$1M, EBIT declined 10.23% from -$1.66M to -$1.83M, and total revenue declined 7.24% from $13.97M to $12.96M.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 5/13/2022 due to a decline in the growth index and total return index. Operating cash flow declined 337.35% from $423 to -$1M, EBIT declined 10.23% from -$1.66M to -$1.83M, and total revenue declined 7.24% from $13.97M to $12.96M.
D
Sell
5/4/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
E
Sell
5/1/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 05/01/2022.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell
4/20/2022Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index.
D
Sell
3/15/2022Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/15/2022 due to an increase in the growth index and solvency index. Operating cash flow increased 145.68% from -$926 to $423, and total revenue increased 1.4% from $13.78M to $13.97M.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/15/2022 due to an increase in the growth index and solvency index. Operating cash flow increased 145.68% from -$926 to $423, and total revenue increased 1.4% from $13.78M to $13.97M.
D
Sell
11/8/2021Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index and valuation index. Earnings per share declined from -$0.0004 to -$0.01.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index and valuation index. Earnings per share declined from -$0.0004 to -$0.01.
D
Sell
8/4/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 8/4/2020 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 111.91% from -$1.79M to $213, and EBIT increased 71.63% from -$1.36M to -$387.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 8/4/2020 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 111.91% from -$1.79M to $213, and EBIT increased 71.63% from -$1.36M to -$387.
D
Sell
7/30/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 7/30/2020 due to an increase in the volatility index and total return index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 7/30/2020 due to an increase in the volatility index and total return index.
E
Sell
7/15/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 7/15/2020 due to a decline in the volatility index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 7/15/2020 due to a decline in the volatility index.
D
Sell
6/26/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 6/26/2020 due to an increase in the volatility index, total return index and valuation index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 6/26/2020 due to an increase in the volatility index, total return index and valuation index.
E
Sell
6/11/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 6/11/2020 due to a decline in the volatility index and valuation index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 6/11/2020 due to a decline in the volatility index and valuation index.
D
Sell
5/27/2020Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 5/27/2020 due to an increase in the volatility index.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D- from E+ on 5/27/2020 due to an increase in the volatility index.
E
Sell
5/8/2020Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 5/8/2020 due to a substantial decline in the solvency index, growth index and efficiency index. Operating cash flow declined 2,419.72% from -$71 to -$1.79M, EBIT declined 328.93% from -$318 to -$1.36M, and net income declined 55.33% from -$1.61M to -$2.49M.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to E+ from D- on 5/8/2020 due to a substantial decline in the solvency index, growth index and efficiency index. Operating cash flow declined 2,419.72% from -$71 to -$1.79M, EBIT declined 328.93% from -$318 to -$1.36M, and net income declined 55.33% from -$1.61M to -$2.49M.
D
Sell
4/3/2019Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2019 due to a noticeable decline in the growth index, efficiency index and volatility index. Net income declined 1,698% from -$3.15M to -$56.69M, earnings per share declined from -$0.24 to -$4.3032, and EBIT declined 1,228.05% from -$385 to -$5.11M.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2019 due to a noticeable decline in the growth index, efficiency index and volatility index. Net income declined 1,698% from -$3.15M to -$56.69M, earnings per share declined from -$0.24 to -$4.3032, and EBIT declined 1,228.05% from -$385 to -$5.11M.
D
Sell
11/19/2018Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/19/2018 due to a large increase in the growth index, efficiency index and solvency index. EBIT increased 60.39% from -$972 to -$385, earnings per share increased from -$0.3823 to -$0.24, and net income increased 36.97% from -$5M to -$3.15M.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/19/2018 due to a large increase in the growth index, efficiency index and solvency index. EBIT increased 60.39% from -$972 to -$385, earnings per share increased from -$0.3823 to -$0.24, and net income increased 36.97% from -$5M to -$3.15M.
D
Sell
4/3/2018Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2018 due to a noticeable decline in the efficiency index, growth index and solvency index. EBIT declined 314.82% from -$1.36M to -$5.63M, net income declined 233.79% from -$8.51M to -$28.42M, and earnings per share declined from -$5.64 to -$18.7638.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 4/3/2018 due to a noticeable decline in the efficiency index, growth index and solvency index. EBIT declined 314.82% from -$1.36M to -$5.63M, net income declined 233.79% from -$8.51M to -$28.42M, and earnings per share declined from -$5.64 to -$18.7638.
D
Sell
11/22/2017Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/22/2017 due to an increase in the total return index, efficiency index and volatility index. Net income increased 12.16% from -$9.69M to -$8.51M.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 11/22/2017 due to an increase in the total return index, efficiency index and volatility index. Net income increased 12.16% from -$9.69M to -$8.51M.
D
Sell
3/31/2017Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/31/2017 due to a decline in the growth index, total return index and volatility index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/31/2017 due to a decline in the growth index, total return index and volatility index.
D
Sell
3/28/2016Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/28/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Net income increased 273.23% from -$6.69M to $11.59M, earnings per share increased from -$0.6412 to $0.9745, and operating cash flow increased 98.53% from -$4.94M to -$72.8.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D from D- on 3/28/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Net income increased 273.23% from -$6.69M to $11.59M, earnings per share increased from -$0.6412 to $0.9745, and operating cash flow increased 98.53% from -$4.94M to -$72.8.
D
Sell
3/11/2016Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell
1/12/2016Downgrade
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
Xtant Medical Holdings, Inc. (XTNT) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
D
Sell
12/28/2015Upgraded
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D on 12/28/2015 due to an increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.74 to 1.27.
Xtant Medical Holdings, Inc. (XTNT) was upgraded to D+ from D on 12/28/2015 due to an increase in the solvency index, valuation index and total return index. The quick ratio increased from 0.74 to 1.27.
AMEX
10/11/2024 4:00PM Eastern
Quotes delayed
